(NYSE: PRGO) Perrigo Co's forecast annual revenue growth rate of 0.34% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 7.97%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.32%.
Perrigo Co's revenue in 2026 is $4,253,100,000.On average, 6 Wall Street analysts forecast PRGO's revenue for 2026 to be $578,677,875,808, with the lowest PRGO revenue forecast at $552,386,849,576, and the highest PRGO revenue forecast at $598,912,330,552. On average, 6 Wall Street analysts forecast PRGO's revenue for 2027 to be $584,596,797,944, with the lowest PRGO revenue forecast at $555,139,836,616, and the highest PRGO revenue forecast at $611,989,018,992.
In 2028, PRGO is forecast to generate $591,754,564,248 in revenue, with the lowest revenue forecast at $561,609,356,160 and the highest revenue forecast at $613,227,863,160.